[ Price : $8.95]
Sanofi asks FDA to remove its Type 1 diabetes therapy Tzield from the agencys National Priority Voucher review program following a...[ Price : $8.95]
A Brookings Institution health economist voices support for FDAs revisions to a guidance on questions and answers about biosimilar...[ Price : $8.95]
Five Hogan Lovells attorneys say a House Appropriations Committee report could prohibit FDA from accepting drug IND trial data fro...[ Price : $8.95]
FDA releases the form FDA-483 with 10 observations from a 2025 inspection at Indias Somerset Therapeutics Private Limited.[ Price : $8.95]
FDA posts a new guidance detailing how manufacturers should design and submit regulatory applications for patient-matched guides u...[ Price : $8.95]
Some 30 bipartisan House members urge FDA to expedite its review of new mental health therapies.[ Price : $8.95]
FDA launches a pilot program using one-day inspectional assessments as part of a broader effort to modernize its oversight model a...[ Price : $8.95]
FDA commissioner Marty Makary says the agency is undertaking a major hiring push and a series of operational reforms aimed at stre...